We are live on ! Find out more
IDYA icon

IDEAYA Biosciences
IDYA

204 hedge funds and large institutions have $3.47B invested in IDEAYA Biosciences in 2024 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 78 increasing their positions, 52 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

392% more first-time investments, than exits

New positions opened: 59 | Existing positions closed: 12

132% more call options, than puts

Call options by funds: $1.4M | Put options by funds: $601K

50% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 52

45% more capital invested

Capital invested by funds: $2.4B → $3.47B (+$1.07B)

30% more funds holding

Funds holding: 157 → 204 (+47)

1.53% more ownership

Funds ownership: 104.51% → 106.05% (+1.5%)

33% less funds holding in top 10

Funds holding in top 10: 6 → 4 (-2)

Holders
204
Holders Change
+47
Holders Change %
+29.94%
% of All Funds
2.94%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
59
Increased
78
Reduced
52
Closed
12
Calls
$1.4M
Puts
$601K
Net Calls
+$794K
Net Calls Change
+$505K

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$398M
2
Fiera Capital (Canada)
Fiera Capital (Canada)
Quebec, Canada
+$46.8M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$41.8M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$29.2M
5
BlackRock
BlackRock
New York
+$22.7M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$73.2M
2
APM
Avidity Partners Management
Texas
-$31M
3
SI
Sofinnova Investments
California
-$29.1M
4
BI
BVF Inc
California
-$24.4M
5
PIM
Platinum Investment Management
Australia
-$21.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
ET
126
Entropy Technologies
New York
$679K +$665K +15,473 New
Principal Financial Group
127
Principal Financial Group
Iowa
$670K +$27.9K +648 +4%
CSS
128
Cubist Systematic Strategies
Connecticut
$669K +$199K +4,626 +44%
Allianz Asset Management
129
Allianz Asset Management
Germany
$654K -$211K -4,900 -25%
LCM
130
Legato Capital Management
California
$649K +$99.2K +2,307 +18%
MAM
131
Martingale Asset Management
Massachusetts
$631K +$263K +6,121 +74%
CUAMC
132
China Universal Asset Management Company
China
$630K +$296K +6,894 +92%
Mirae Asset Global Investments
133
Mirae Asset Global Investments
South Korea
$628K -$328K -7,632 -22%
ZCM
134
Ziegler Capital Management
Illinois
$610K +$55K +1,278 +10%
Boston Partners
135
Boston Partners
Massachusetts
$588K +$576K +13,391 New
RAM
136
Redmond Asset Management
Virginia
$560K -$1.72K -40 -0.3%
Teacher Retirement System of Texas
137
Teacher Retirement System of Texas
Texas
$551K +$99.8K +2,322 +23%
OAC
138
OMERS Administration Corp
Ontario, Canada
$491K +$482K +11,200 New
Canada Life
139
Canada Life
Manitoba, Canada
$487K +$261K +6,069 +121%
Prudential Financial
140
Prudential Financial
New Jersey
$465K +$456K +10,605 New
OAM
141
Oppenheimer Asset Management
New York
$459K +$450K +10,466 New
American Century Companies
142
American Century Companies
Missouri
$436K -$33.4K -776 -7%
EFM
143
E Fund Management
China
$417K -$37.5K -873 -8%
Public Employees Retirement Association of Colorado
144
Public Employees Retirement Association of Colorado
Colorado
$405K +$396K +9,221 New
CIBC World Market
145
CIBC World Market
Ontario, Canada
$389K +$381K +8,867 New
HSBC Holdings
146
HSBC Holdings
United Kingdom
$372K -$116K -2,693 -24%
Mariner
147
Mariner
Kansas
$339K +$332K +7,727 New
Creative Planning
148
Creative Planning
Kansas
$308K +$54.2K +1,261 +22%
DB
149
Danske Bank
Denmark
$305K +$299K +6,945 New
CC
150
Callan Capital
California
$295K – – –
4 5
6
7 8

IDYA Hedge Fund Activity: Q1 2024 in Review

204 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in IDEAYA Biosciences (IDYA) for Q1 2024, worth a combined $3.47B — up 45% from $2.4B a quarter earlier.

Buyers outnumbered sellers: 59 funds opened new IDYA positions and 12 closed out — a net gain of 47 holders — while 78 added to existing stakes and 52 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $398M. The largest seller was Morgan Stanley, cutting an estimated $73.2M.

  • 204 institutional investors held IDEAYA Biosciences (IDYA) as of Q1 2024, up from 157 in Q4 2023.
  • Funds reported $3.47B of IDEAYA Biosciences stock for Q1 2024, up 45% quarter-over-quarter.
  • 59 funds opened new IDEAYA Biosciences positions in Q1 2024 and 12 closed out, a net change of +47 holders.
  • The largest IDEAYA Biosciences buyer in Q1 2024 was Fidelity Investments, an estimated $398M added.
  • The largest IDEAYA Biosciences seller in Q1 2024 was Morgan Stanley, an estimated $73.2M sold.

Based on aggregated 13F filings for Q1 2024.